Company: SONM
Filing Date: 2025-12-05
Form Type: DEFM14A
Source: 0001493152-25-026277
Chunk: 323

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-12-05
Form: DEFM14A
Chunk 323
---
 a stockholder rights plan, as set forth in the Rights Agreement, dated as of April 21, 2025 (the “Rights Agreement”), by and between the Company and Equiniti Trust Company, LLC, a New York limited liability company, as rights agent. The dividend is payable to stockholders of record of the Company as of the close of business on May 2, 2025.

Each Right will allow its holder to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock (the “Preferred Shares”), par value $0.001 per share, for $4.00 (the “Purchase Price”), once the Rights become exercisable. The Purchase Price payable, and the number of Preferred Shares or other securities or other property issuable upon exercise of the Rights will be subject to adjustment from time to time to prevent dilution in the event of a stock dividend on, or a subdivision, combination or reclassification of, the Preferred Shares. The Rights are exercisable only if a person or group acquires 15.5% or more of the Company’s outstanding common stock (an amount of “less than 20%” in the case of a passive institutional investor as described in the Rights Plan), commences tender or exchange offer, or a similar event, as described in detail in the Purchase Agreement.

NOTE 6 — Stock-Based Compensation

Stock-based compensation expense is as follows:

Schedule of Stock Based Compensation Expense

|                            |     |               2025 |     |     | 2024 |     |     |              2025 |       |     | 2024 |       |
|                            |     | Three Months Ended |     |     |      |     |     | Nine Months Ended |       |     |      |       |
|                            |     |      September 30, |     |     |      |     |     |     September 30, |       |     |      |       |
|                            |     |               2025 |     |     | 2024 |     |     |              2025 |       |     | 2024 |       |
| Cost of revenues           |     |                  $ |  12 |     |    $ |  15 |     |                 $ |    27 |     |    $ |    42 |
| Research and development   |     |                    |   9 |     |      |  15 |     |                   |    23 |